Sage Submissions
has released Sage Templates, version 1.1.3. Sage Templates OneVoice feature enables documents to be created across the organization and by outside authors with a consistent look-and-feel. This enables the creation of consistent formatted submissions instead of several formats and document navigation structures.
Extensive customer input was gathered to enhance the design of Sage Templates and to extend the number of templates available to authors of submission documents with Version 1.1.3. Sage Templates are available as a complete set for all stages of submissions in North American and Europe and includes:
· US eCTD
· EU eCTD
· IND
· CTA-IMPD templates for Europe and
· CTA-A templates for Canada
Templates are also available as subsets to provide a low cost acquisition point for companies that prepare Drug Master Files, CROs that conduct nonclinical or clinical studies, or companies that submit only IND, CTA-IMPD or CTA-A submissions.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.